Mark CHAPLIN

Industry representative

United Kingdom

Mark Chaplin Ph.D graduated from the University of St Andrews with a BSc in Cell Biology. He went on to study the role of specific centrosomal proteins at the University of Dundee and attained his Ph.D in 1996. Mark has been in the pharmaceutical industry for nearly 20 years where he has held a number of roles in medical affairs, commercial and medical education. He joined Allergan in 2004 and after recently working on Neurotoxin Global Strategy in California Mark has returned to the United Kingdom to head up Allergan’s medical education program Internationally.